1 insider bought €209k of shares over the last 90 days, the latest by 제넥신, filed 01 Sept 2026.
Who traded when
BuySaleSince the insiders bought
- -15.7%Entry ₩34,650 · Close 30 Oct 2026 ₩29,200
- -15.7%Entry ₩34,650 · Close 30 Oct 2026 ₩29,200
- -60.6%Entry ₩83,700 · Close at T+365 ₩33,000
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- Other0DART
- Other0DART
- Other0DART
- Other0DART
- Other0DART
- Other0DART
- 9,660 sharesShareKRXDART:20260901000014Canonical exit: 30 Nov 2026 (T+90)
- Other0DART
- Other0DART
- Other0DART
- 200 sharesShareKRXDART:20260803000140Canonical exit: 1 Nov 2026 (T+90)
- Other0DART
- 250 sharesKRXDART:20260708000191Canonical exit: 6 Oct 2026 (T+90)
- 250 sharesShareKRXDART:20260708000167Canonical exit: 6 Oct 2026 (T+90)
- 635 shares@ ₩76,643.16080.037% mcap100.0% of flowShareKRXDART:20260504000341
- 625,144 sharesKRXDART:20260407002930
- 680,144 sharesKRXDART:20260407002858Canonical exit: 29 Jun 2025 (T+90)
- 595,144 sharesShareKRXDART:20260407002957
- ●Executives0DART
- 1,500 sharesShareKRXDART:20260113000603
- ●Executives0DART
- 680,144 sharesKRXDART:20250106000208Canonical exit: 27 Mar 2025 (T+90)
- 680,144 sharesShareKRXDART:20250106000241Canonical exit: 6 Apr 2025 (T+90)
- ●Executives0DART
- ShareKRXDART:20240807000427Canonical exit: 31 Oct 2024 (T+90)
25 of 71 declarations
About ToolGen Incorporated
On March 30, 2022, 7 filers at 툴젠 (ToolGen Incorporated) bought on the same day. The record holds 26 purchases against 4 sales (87% purchases) and very few amounts: only 2 purchases are valued, EUR 11,701 for 권순일 (상무) and EUR 10,358 for 한지학 (전무이사), both on February 2, 2024, or EUR 22,059.
한지학 is the top filer with 26 of the 61 filings, 3 of them purchases. 제넥신 (10%이상주주) files 12, with 11 purchases and one sale. 권순일 has 5 (2 purchases, one sale), 김진수 (기타비상무이사) 3, and the company 4, with no trade. Filings run from February 26, 2021 to September 1, 2026: 10 in 2021, 11 in 2022, 20 in 2023, 7 in 2024, 3 in 2025 and 10 in 2026.
Read moreShow less
South Korean health care at KRW 286.8 billion, 17.7% of the capital with insiders, 14 filers. For 11 purchases, a 90-day median of minus 4.2%, 45% of results positive (recorded past results, not a forecast). Latest year: 10 filings, 5 purchases and 3 sales.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
